SCM
ARMP icon

Sterling Capital Management’s Armata Pharmaceuticals ARMP Stock Holding History

Sterling Capital Management’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272 Buy
+42
New +$385 ﹤0.01% 3255

Other funds holding ARMP

GWM
GSB Wealth Management Guilford, Connecticut $498M AUM 27.51% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
CNBT
Cornerstone National Bank & Trust Palatine, Illinois $296M AUM 12.13% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Sterling Capital Management's ARMP Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Armata Pharmaceuticals (ARMP) in Q2 2026: 42 shares worth $272. The stake represents ﹤0.01% of the portfolio and ranks #3255 among its holdings.

10 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Sterling Capital Management held 42 shares of Armata Pharmaceuticals worth $272 as of Q2 2026.
  • Armata Pharmaceuticals was a new Sterling Capital Management position in Q2 2026.
  • Armata Pharmaceuticals made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3255 holding.
  • 10 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.